|
Volumn 177, Issue 4, 2002, Pages 200-204
|
Bronchiectasis in Indigenous children in remote Australian communities
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE;
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIASTHMATIC AGENT;
ANTIBIOTIC AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA LACTAM ANTIBIOTIC;
CEFACLOR;
CEFOTAXIME;
CEFTRIAXONE;
CIPROFLOXACIN;
CORTICOSTEROID DERIVATIVE;
COTRIMOXAZOLE;
METHYLXANTHINE DERIVATIVE;
MUCOLYTIC AGENT;
VACCINE;
ABORIGINE;
ACUTE DISEASE;
ADOLESCENT;
ATELECTASIS;
AUSTRALIA;
BRONCHIECTASIS;
BRONCHITIS;
CHILD;
CHILD NUTRITION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
CYSTIC FIBROSIS;
DISEASE MODEL;
EDUCATION;
HEALTH CARE ACCESS;
HEALTH SERVICE;
HOSPITALIZATION;
HOUSING;
HUMAN;
IMMUNIZATION;
INFANT;
LUNG INFILTRATE;
MAJOR CLINICAL STUDY;
NEWBORN;
PASSIVE SMOKING;
PHYSICAL ACTIVITY;
PHYSIOTHERAPY;
PNEUMONIA;
PREFERRED PROVIDER ORGANIZATION;
PRIMARY HEALTH CARE;
RECURRENT DISEASE;
REVIEW;
SOCIOECONOMICS;
|
EID: 0037135779
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2002.tb04733.x Document Type: Review |
Times cited : (179)
|
References (44)
|